The Only Futures Trading Guide You’ll Ever Need
Regardless of your level of futures trading prowess, our Technical Analysis Guide has something to help you succeed in today’s futures markets.
Download your FREE Technical Analysis Trading Guide Today!
Dane C. Andreeff, insider at Helius Medical Technologies
Dane C. Andreeff Insider Alerts

Get notified the next time Dane C. Andreeff buys or sells Helius Medical Technologies stock. Enter your email address below to get our daily insider buying and selling report.

Dane C. Andreeff Insider Information

Mr. Andreeff is the General Partner and Portfolio Manager of Maple Leaf Partners, L.P. and the President of Andreeff Equity Advisors, L.L.C. Mr. Andreeff has managed investment portfolios since 1996 for Andreeff Equity, L.P., Andreeff Overseas Ltd. and Clover Partners, LP. Prior to managing portfolios, Mr. Andreeff worked as an associate analyst at Furman Selz and Granite Capital International Group. Currently, Mr. Andreeff serves as a Director of TraceSecurity Inc., HDL Therapeutics, Inc. and Myocardial Solutions, Ltd.

Mr. Andreeff received his Master's degree in Economics from the University of Texas at Arlington in 1991 and Bachelor's degree in Economics from the University of Texas at Arlington in 1989.

How do I contact Dane C. Andreeff?

The corporate mailing address for Mr. Andreeff and other Helius Medical Technologies executives is 642 NEWTOWN YARDLEY ROAD SUITE 100, NEWTOWN PA, 18940. Helius Medical Technologies can also be reached via phone at (215) 944-6100 and via email at [email protected]

Has Dane C. Andreeff been buying or selling shares of Helius Medical Technologies?

Over the course of the past ninety days, Dane C. Andreeff has bought $300,000.00 in Helius Medical Technologies stock. Most recently, on Friday, November 12th, Dane Andreeff bought 37,500 shares of Helius Medical Technologies stock. The stock was acquired at an average cost of $8.00 per share, with a total value of $300,000.00.

Are insiders buying or selling shares of Helius Medical Technologies?

In the last twelve months, Helius Medical Technologies insiders bought shares 1 times. They purchased a total of 37,500 shares worth more than $300,000.00. The most recent insider tranaction occured on November, 12th when CEO Dane Andreeff bought 37,500 shares worth more than $300,000.00. Insiders at Helius Medical Technologies own 17.4 % of the company.

Information on this page was last updated on 11/12/2021.

Dane C. Andreeff Insider Trading History at Helius Medical Technologies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/12/2021Buy37,500$8.00$300,000.00View SEC Filing Icon  
6/27/2018Buy10,000$10.10$101,000.00View SEC Filing Icon  
12/22/2017Buy255,101$1.96$499,997.96View SEC Filing Icon  
11/13/2017Buy167,000$2.58$430,860.00View SEC Filing Icon  
See Full Table

Dane C. Andreeff Buying and Selling Activity at Helius Medical Technologies

This chart shows Dane Andreeff's buying and selling at Helius Medical Technologies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Helius Medical Technologies Company Overview

Helius Medical Technologies logo
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational Portable Neuromodulation Stimulator (PoNS), that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.
Read More

Today's Range

Now: $5.63
Low: $5.24
High: $5.82

50 Day Range

MA: $11.43
Low: $5.54
High: $14.50

2 Week Range

Now: $5.63
Low: $5.24
High: $34.00

Volume

40,142 shs

Average Volume

45,325 shs

Market Capitalization

$13.46 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.99
Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!